Rebecca E. Ling

412 total citations
9 papers, 152 citations indexed

About

Rebecca E. Ling is a scholar working on Public Health, Environmental and Occupational Health, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Rebecca E. Ling has authored 9 papers receiving a total of 152 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Public Health, Environmental and Occupational Health, 3 papers in Oncology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Rebecca E. Ling's work include Acute Lymphoblastic Leukemia research (4 papers), Acute Myeloid Leukemia Research (2 papers) and Viral-associated cancers and disorders (2 papers). Rebecca E. Ling is often cited by papers focused on Acute Lymphoblastic Leukemia research (4 papers), Acute Myeloid Leukemia Research (2 papers) and Viral-associated cancers and disorders (2 papers). Rebecca E. Ling collaborates with scholars based in United Kingdom, China and Austria. Rebecca E. Ling's co-authors include Wei Wang, Peter Sullivan, Anindita Roy, Thomas Jackson, Véronique Minard‐Colin, Andishe Attarbaschi, Birgit Burkhardt, Joe W. Cross, Mary Taj and Britta Maecker‐Kolhoff and has published in prestigious journals such as Blood, Cochrane Database of Systematic Reviews and Frontiers in Immunology.

In The Last Decade

Rebecca E. Ling

8 papers receiving 148 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rebecca E. Ling United Kingdom 5 49 45 27 26 24 9 152
Carolina Santamaría‐Ulloa Costa Rica 10 16 0.3× 15 0.3× 10 0.4× 53 2.0× 5 0.2× 31 253
Marjan Walli-Attaei Canada 6 14 0.3× 12 0.3× 16 0.6× 54 2.1× 4 0.2× 14 219
Ruying Hu China 8 41 0.8× 9 0.2× 15 0.6× 21 0.8× 2 0.1× 23 223
Deena Alasfoor Oman 10 10 0.2× 72 1.6× 9 0.3× 21 0.8× 17 0.7× 16 221
Seyed Alireza Mosavi Jarrahi Iran 7 33 0.7× 64 1.4× 3 0.1× 10 0.4× 3 0.1× 26 255
Manas Kaushik United States 4 50 1.0× 92 2.0× 17 0.6× 32 1.2× 1 0.0× 5 240
Lhamo Yangchen Sherpa Norway 7 51 1.0× 20 0.4× 9 0.3× 26 1.0× 2 0.1× 9 257
Ann Keeling Belgium 4 11 0.2× 22 0.5× 7 0.3× 27 1.0× 3 0.1× 17 152
Supriya Dwivedi India 5 17 0.3× 36 0.8× 5 0.2× 6 0.2× 4 0.2× 11 118
Amelia VanderZanden United States 6 5 0.1× 21 0.5× 19 0.7× 33 1.3× 2 0.1× 13 134

Countries citing papers authored by Rebecca E. Ling

Since Specialization
Citations

This map shows the geographic impact of Rebecca E. Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebecca E. Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebecca E. Ling more than expected).

Fields of papers citing papers by Rebecca E. Ling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rebecca E. Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebecca E. Ling. The network helps show where Rebecca E. Ling may publish in the future.

Co-authorship network of co-authors of Rebecca E. Ling

This figure shows the co-authorship network connecting the top 25 collaborators of Rebecca E. Ling. A scholar is included among the top collaborators of Rebecca E. Ling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rebecca E. Ling. Rebecca E. Ling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Melton, Hollie, Rebecca E. Ling, John Moppett, et al.. (2025). Do Surveillance Tests for Relapse Improve Survival After Chemotherapy for Paediatric Acute Leukaemia? A Systematic Review. Pediatric Blood & Cancer. 72(12). e31973–e31973. 1 indexed citations
2.
Bomken, Simon, Rebecca E. Ling, Arina Lazareva, et al.. (2024). Management of paediatric monomorphic post‐transplant lymphoproliferative disorders with low‐intensity treatment: A multicentre international experience. Pediatric Blood & Cancer. 71(8). e31053–e31053. 1 indexed citations
3.
Ling, Rebecca E., Joe W. Cross, & Anindita Roy. (2024). Aberrant stem cell and developmental programs in pediatric leukemia. Frontiers in Cell and Developmental Biology. 12. 1372899–1372899. 2 indexed citations
4.
Ling, Rebecca E., Thomas Jackson, Natalina Elliott, et al.. (2024). The Fetal Specific Gene LIN28B Is Essential for Human Fetal B-Lymphopoiesis and Initiation of KMT2A-AFF1+ Infant Acute Lymphoblastic Leukemia. Blood. 144(Supplement 1). 199–199.
5.
Taj, Mary, Britta Maecker‐Kolhoff, Rebecca E. Ling, et al.. (2021). Primary post‐transplant lymphoproliferative disorder of the central nervous system: characteristics, management and outcome in 25 paediatric patients. British Journal of Haematology. 193(6). 1178–1184. 10 indexed citations
6.
Jackson, Thomas, Rebecca E. Ling, & Anindita Roy. (2021). The Origin of B-cells: Human Fetal B Cell Development and Implications for the Pathogenesis of Childhood Acute Lymphoblastic Leukemia. Frontiers in Immunology. 12. 637975–637975. 18 indexed citations
7.
Ling, Rebecca E., et al.. (2011). Nutritional risk in hospitalised children: An assessment of two instruments. e-SPEN the European e-Journal of Clinical Nutrition and Metabolism. 6(3). e153–e157. 43 indexed citations
8.
Ling, Rebecca E., Sheena Derry, R Andrew Moore, & Philip J Wiffen. (2010). Rizatriptan for acute migraine headaches in adults. Cochrane Database of Systematic Reviews. 4 indexed citations
9.
Ling, Rebecca E., et al.. (2010). Emerging issues in public health: A perspective on China’s healthcare system. Public Health. 125(1). 9–14. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026